Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT06372613

Association Between LRG and Histologic Remission in Ulcerative Colitis

Conditions: Ulcerative Colitis in Histologic Remission

Sex: All

Ages: 20 Years – 90 Years

Healthy volunteers: No

Enrollment: 100

Sponsor: Showa Inan General Hospital

Location: Showa Inan General Hospital Komagane

Summary

We attempt to clarify the serum leucine-rich α 2-glycoprotein (LRG) level which can predict histologic remission in ulcerative colitis patients in this study. Colonoscopy with histology will be performed annually, irrespective of symptoms or serum LRG values. Serum LRG levels are analyzed by an enzyme-linked immunosorbent assay.

Eligibility Criteria

Inclusion Criteria: * definitive UC patients based on the standard criteria Exclusion Criteria: * None

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06372613). StuddyBuddy aggregates publicly available trial information.